A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Nemunaitis, MD
Gradalis, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Los Angeles, California, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Nicklaus Children'S Hospital
Miami, Florida, United States
- Dana-Farber/boston Children'S Cancer and Blood Disorders
Boston, Massachusetts, United States
- Washington University Siteman Cancer Center
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Duke Children'S Hospital and Health Center; Duke Cancer Institute
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Texas Oncology - Pediatrics
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Aug 2018
- Primary completion
- 20 Jan 2022
- Completion
- 20 Jan 2022
- Last update posted
- 26 Apr 2023
- Registered enrollment
- 32
- Registry id
- NCT03495921
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.